Repurposing existing drugs for COVID-19 offers a more rapid alternative to a vaccine

(University of Cambridge) Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today.